Pharma & Biotech

The fate of CureVac hangs in the balance as shareholders approach a critical decision point regarding BioNTech's acquisition proposal. With...

The healthcare conglomerate Johnson & Johnson finds itself navigating a complex landscape defined by stellar financial performance on one hand...

Iovance Biotherapeutics has sent shockwaves through the biotechnology sector with the release of pivotal interim data from its registration-directed Phase...

Investors in Denali Therapeutics are bracing for a pivotal market update as the biotechnology firm prepares to release its third-quarter...

The investment community is closely monitoring Reviva Pharmaceuticals Holdings as the company approaches a critical regulatory milestone. Market experts are...

Krystal Biotech has delivered a stunning quarterly report that significantly surpassed market projections, demonstrating both robust commercial execution and strategic...

All eyes are on BridgeBio Pharma as the biotechnology firm approaches a pivotal medical conference that could significantly influence its...

While numerous financial assets struggle to maintain momentum, Hercules Capital continues to post exceptional results. This specialized lender to technology...

While Dynavax shares opened today's session down 1.3% at $10.26, institutional investors continue demonstrating strong confidence in the biotechnology firm....

PDS Biotechnology Corp (PDSB) is approaching a week of significant developments, with two major catalysts on the horizon. The clinical-stage...